AppLovin, IBD Stock Of The Day, Earns Positive Reviews For New Service
Briefly

UBS analyst Chris Kuntarich noted that a beauty brand executive is optimistic about spending with AppLovin for e-commerce ads, highlighting the platform's promising results.
Oppenheimer analyst Martin Yang referred to AppLovin's recent drop in stock price as 'a very good buying opportunity for one of the most exciting growth companies at a reasonable valuation'.
Jefferies analyst James Heaney described AppLovin stock as a 'top pick for 2025', driven by its expanding share in e-commerce advertising.
AppLovin is shifting focus beyond mobile game ads to diversify its offerings, reinforced by favorable reviews for its new e-commerce advertising service.
Read at Investor's Business Daily
[
|
]